BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19

• Press Releases

  Onco3R Therapeutics Announces Completion of First Multiple Ascending Dose Cohort in Phase 1 Trial of Novel SIK3 inhibitor O3R-5671

  December 3, 2025

   · 

  4 min read
• Press Releases

  AlzeCure Receives Payment of EU Grant for Phase 2 Clinical Trial with NeuroRestore ACD856 for Alzheimer’s Disease

  December 3, 2025

   · 

  6 min read
• Press Releases

  Sapu Nano Unveils Broad-Applicability Deciparticle™ Nanomedicine Platform Capable of Formulating Multiple Hydrophobic Peptide, Macrolide, and Polyketide Drugs

  December 3, 2025

   · 

  2 min read
• Press Releases

  Pentixapharm Advances Regulatory Preparations for Phase 3 PANDA Study with Radiodiagnostic Candidate 68Ga-PentixaFor in Hypertension

  December 3, 2025

   · 

  3 min read
• Press Releases

  Elevation Spine Center Expands Bend Clinic to Offer Easier Access to Advanced, Lasting Pain Relief

  December 3, 2025

   · 

  4 min read
• Press Releases

  Actithera appoints radiopharmaceutical pioneer Dr. Darshan Dalal as Chief Medical Officer

  December 3, 2025

   · 

  3 min read
• Press Releases

  Alligator Bioscience Publishes Financial Calendar for 2026

  December 3, 2025

   · 

  1 min read
• Press Releases

  New Data Presented at the Clinical Trials on Alzheimer’s Disease (CTAD) Conference 2025 Confirms Pharmacological Effect of LEQEMBI® (lecanemab-irmb) on Neurotoxic Aβ Protofibrils in CSF

  December 3, 2025

   · 

  21 min read
• Press Releases

  New Data to be Presented at the 2025 SABCS Demonstrates Potential Expanded Utility of the Breast Cancer Index Test, the Leading Biomarker in Personalizing Endocrine Therapy Duration

  December 3, 2025

   · 

  12 min read
• Press Releases

  Baxdrostat New Drug Application accepted under FDA Priority Review in the US for patients with hard-to-control hypertension

  December 3, 2025

   · 

  11 min read